Updates in wet AMD from ASRS 2026 include real-world data on anti-VEGF treatment persistence, ELARA data on aflibercept 8 mg, as well as two studies showing reduced injection burden via gene therapy. Medscape
Tag: ReCAP
Advances in Neovascular Macular Degeneration From ASRS 2025
Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as emerging gene therapies, as reported by Dr Sunir Garg. Medscape
Dry AMD Highlights From ASRS 2024
Key data on dry age-related macular degeneration and geographic atrophy from ASRS 2024 include real-world experience of recently approved therapies and emerging agents with new mechanisms of action. Medscape